Role of osteopontin in rheumatoid arthritis

Rheumatology International

Volumn 35, Issue 4, 2015, Pages 589-595

  Zhang, Fangjie ^a   Luo, Wei ^a   Li, Yusheng ^a   Gao, Shuguang ^a   Lei, Guanghua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Integrins; Osteopontin; Pathogenesis; Rheumatoid arthritis

Indexed keywords

AUTOANTIGEN; CYTOKINE; NEUTRALIZING ANTIBODY; OSTEOPONTIN; SMALL INTERFERING RNA;

ANIMAL MODEL; CYTOKINE PRODUCTION; DRUG TARGETING; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; ANIMAL; ARTICULAR CARTILAGE; METABOLISM; PATHOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; HUMANS; OSTEOPONTIN; SYNOVIAL MEMBRANE;

EID: 84925241070     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3122-z     Document Type: Review

References (68)

1. Scott DL, Symmons DP, Coulton BL, Popert AJ (1987) Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1:1108–1111
2. Carmona L, Cross M, Williams B, Lassere M, March L (2010) Rheumatoid arthritis. Best Pract Res Clin Rheumatol 24:733–745
3. Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376:1094–1108
4. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429–442
5. Kinne RW, Stuhlmuller B, Burmester GR (2007) Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res Ther 9:224
6. Bresnihan B (1999) Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 26:717–719
7. Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW (1997) Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum 40:5–18
8. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR (2000) Macrophages in rheumatoid arthritis. Arthritis Res 2:189–202
9. Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233:233–255
10. Noss EH, Brenner MB (2008) The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 223:252–270
11. Wehrens EJ, Prakken BJ, van Wijk F (2013) T cells out of control—impaired immune regulation in the inflamed joint. Nat Rev Rheumatol 9:34–42
12. Scheel T, Gursche A, Zacher J, Haupl T, Berek C (2011) V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum 63:63–72
13. Mauri C, Ehrenstein MR (2007) Cells of the synovium in rheumatoid arthritis. B cells. Arthritis Res Ther 9:205
14. Gravallese EM (2003) Osteopontin: a bridge between bone and the immune system. J Clin Invest 112:147–149
15. Zhang FJ, Gao SG, Cheng L, Tian J, Xu WS, Luo W, Song Y, Yang Y, Lei GH (2013) The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee. Rheumatol Int 33:79–83
16. Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 30–31:92–102
17. Lampe MA, Patarca R, Iregui MV, Cantor H (1991) Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol 147:2902–2906
18. Patarca R, Freeman GJ, Singh RP et al (1989) Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 170:145–161
19. Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW (1990) cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 7:491–502
20. Denhardt DT, Guo X (1993) Osteopontin: a protein with diverse functions. FASEB J 7:1475–1482
21. O’Regan A, Berman JS (2000) Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 81:373–390
22. Weber GF (2001) The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 1552:61–85
23. Bautista DS, Denstedt J, Chambers AF, Harris JF (1996) Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones. J Cell Biochem 61:402–409
24. Yokosaki Y, Matsuura N, Sasaki T et al (1999) The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J Biol Chem 274:36328–36334
25. Sato I, Yamamoto N, Yamazaki H, Hashimoto S, Hino M, Sakai F, Fujie A (2005) Prevention of the cryptic epitope SLAYGLR within osteopontin does not influence susceptibility to Candida albicans infection. Antimicrob Agents Chemother 49:3053–3055
26. Green PM, Ludbrook SB, Miller DD, Horgan CM, Barry ST (2001) Structural elements of the osteopontin SVVYGLR motif important for the interaction with alpha(4) integrins. FEBS Lett 503:75–79
27. Sharif SA, Du X, Myles T et al (2009) Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis. Arthritis Rheum 60:2902–2912
28. Myles T, Nishimura T, Yun TH et al (2003) Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J Biol Chem 278:51059–51067
29. Barry ST, Ludbrook SB, Murrison E, Horgan CM (2000) Analysis of the alpha4beta1 integrin–osteopontin interaction. Exp Cell Res 258:342–351
30. Barry ST, Ludbrook SB, Murrison E, Horgan CM (2000) A regulated interaction between alpha5beta1 integrin and osteopontin. Biochem Biophys Res Commun 267:764–769
31. Gladson CL, Cheresh DA (1991) Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88:1924–1932
32. Wai PY, Kuo PC (2008) Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 27:103–118
33. Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW (1995) A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem 270:26232–26238
34. Bayless KJ, Meininger GA, Scholtz JM, Davis GE (1998) Osteopontin is a ligand for the alpha4beta1 integrin. J Cell Sci 111(Pt 9):1165–1174
35. Denda S, Reichardt LF, Muller U (1998) Identification of osteopontin as a novel ligand for the integrin alpha8 beta1 and potential roles for this integrin–ligand interaction in kidney morphogenesis. Mol Biol Cell 9:1425–1435
36. Hultenby K, Reinholt FP, Heinegard D, Andersson G, Marks SJ (1995) Osteopontin: a ligand for the alpha v beta 3 integrin of the osteoclast clear zone in osteopetrotic (ia/ia) rats. Ann NY Acad Sci 760:315–318
37. von Wolff M, Strowitzki T, Becker V, Zepf C, Tabibzadeh S, Thaler CJ (2001) Endometrial osteopontin, a ligand of beta3-integrin, is maximally expressed around the time of the “implantation window”. Fertil Steril 76:775–781
38. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor–ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509–512
39. Christensen B, Kazanecki CC, Petersen TE, Rittling SR, Denhardt DT, Sorensen ES (2007) Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J Biol Chem 282:19463–19472
40. Sodek J, Ganss B, McKee MD (2000) Osteopontin. Crit Rev Oral Biol Med 11:279–303
41. Wai PY, Kuo PC (2004) The role of osteopontin in tumor metastasis. J Surg Res 121:228–241
42. Petrow PK, Hummel KM, Schedel J et al (2000) Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum 43:1597–1605
43. Ohshima S, Yamaguchi N, Nishioka K et al (2002) Enhanced local production of osteopontin in rheumatoid joints. J Rheumatol 29:2061–2067
44. Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, Ni L, Xu R, Hong J, Zhang JZ (2005) Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060–1067
45. Zheng W, Li R, Pan H, He D, Xu R, Guo TB, Guo Y, Zhang JZ (2009) Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis. Arthritis Rheum 60:1957–1965
46. Chen G, Zhang X, Li R, Fang L, Niu X, Zheng Y, He D, Xu R, Zhang JZ (2010) Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheum 62:2900–2908
47. Ohshima S, Kobayashi H, Yamaguchi N et al (2002) Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis. Arthritis Rheum 46:1094–1101
48. Iwadate H, Kobayashi H, Kanno T et al (2014) Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients. Int J Rheum Dis 17:50–56
49. Ji HI, Lee SH, Song R et al (2014) Serum level of osteopontin as an inflammatory marker does not indicate disease activity or responsiveness to therapeutic treatments in patients with rheumatoid arthritis. Clin Rheumatol 33:397–402
50. Gattorno M, Gregorio A, Ferlito F et al (2004) Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis. Rheumatology (Oxford) 43:1091–1096
51. Hasegawa M, Nakoshi Y, Iino T, Sudo A, Segawa T, Maeda M, Yoshida T, Uchida A (2009) Thrombin-cleaved osteopontin in synovial fluid of subjects with rheumatoid arthritis. J Rheumatol 36:240–245
52. Shio K, Kobayashi H, Asano T et al (2010) Thrombin-cleaved osteopontin is increased in urine of patients with rheumatoid arthritis. J Rheumatol 37:704–710
53. Xu G, Sun W, He D, Wang L, Zheng W, Nie H, Ni L, Zhang D, Li N, Zhang J (2005) Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism. J Rheumatol 32:410–416
54. Marciano R, Giacopelli F, Divizia MT et al (2006) A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis. Ann Rheum Dis 65:662–665
55. Gazal S, Sacre K, Allanore Y et al (2014) Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204581
56. Take Y, Nakata K, Hashimoto J, Tsuboi H, Nishimoto N, Ochi T, Yoshikawa H (2009) Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6. Arthritis Rheum 60:3591–3601
57. Asano T, Iwasaki N, Kon S, Kanayama M, Morimoto J, Minami A, Uede T (2014) alpha9beta1 integrin acts as a critical intrinsic regulator of human rheumatoid arthritis. Rheumatology (Oxford) 53:415–424
58. Yumoto K, Ishijima M, Rittling SR et al (2002) Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA 99:4556–4561
59. Ishii T, Ohshima S, Ishida T et al (2004) Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. Biochem Biophys Res Commun 316:809–815
60. Yamamoto N, Sakai F, Kon S et al (2003) Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 112:181–188
61. Kanayama M, Kurotaki D, Morimoto J et al (2009) Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J Immunol 182:8015–8025
62. Kanayama M, Morimoto J, Matsui Y et al (2011) alpha9beta1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation. J Immunol 187:5851–5864
63. Takanashi M, Oikawa K, Sudo K et al (2009) Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse. Gene Ther 16:982–989
64. Sakata M, Tsuruha JI, Masuko-Hongo K et al (2001) Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 28:1492–1495
65. Fan K, Dai J, Wang H, Wei H et al (2008) Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells. Arthritis Rheum 58:2041–2052
66. Yamamoto N, Nakashima T, Torikai M, Naruse T, Morimoto J, Kon S, Sakai F, Uede T (2007) Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody. Int Immunopharmacol 7:1460–1470
67. Wilder RL (2002) Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis 61(Suppl 2):i96–i99
68. Boumans MJ, Houbiers JG, Verschueren P et al (2012) Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study. Ann Rheum Dis 71:180–185